Single low-dose primaquine to reduce malaria transmission

The Lancet Infectious Diseases

Volumn 14, Issue 2, 2014, Pages 91-92

  Steketee, Richard W ^a   Ter Kuile, Feiko ^b  

^a PATH   (United States)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; PRIMAQUINE; ANTIMALARIAL AGENT;

CLINICAL EFFECTIVENESS; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG SAFETY; GAMETOCYTE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; LETTER; LOW DRUG DOSE; MALARIA; MALARIA CONTROL; NUCLEIC ACID SEQUENCE BASED AMPLIFICATION; OPTIMAL DRUG DOSE; PARASITE CLEARANCE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SINGLE DRUG DOSE; FEMALE; MALARIA, FALCIPARUM; MALE;

ANTIMALARIALS; FEMALE; HUMANS; MALARIA, FALCIPARUM; MALE; PRIMAQUINE;

EID: 84892515769     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(13)70288-3     Document Type: Letter

References (10)

1. WHO Evidence Review Group: The safety and effectiveness of single dose primaquine as a P. falciparum gametocytocide. Pullman Hotel, Bangkok, Thailand, 13-15 August 2012 WHO, (accessed Sept 19, 2013). http://www.who.int/malaria/mpac/sep2012/primaquine_single_dose_pf_erg_meeting_report_aug2012.pdf.
2. Updated WHO policy recommendation (October 2012): single dose primaquine as a gametocytocide in Plasmodium falciparum malaria. October, 2012 2012, WHO, World Health Organization, Geneva.
3. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2012 meeting. Malar J 2012, 11:424. WHO Malaria Policy Advisory Committee and Secretariat.
4. Eziefula AC, Bousema T, Yeung S, et al. Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial. Lancet Infect Dis 2013, published online Nov 11. http://dx.doi.org/10.1016/S1473-3099(13)70268-8.
5. Taylor W, Terlouw DJ, Olliaro PL, White NJ, Brasseur P, ter Kuile FO Use of weight-for-age-data to optimize tablet strength and dosing regimens for a new fixed-dose artesunate-amodiaquine combination for treating falciparum malaria. Bull World Health Organ 2006, 84:956-964.
6. White NJ Primaquine to prevent transmission of falciparum malaria. Lancet Infect Dis 2013, 13:175-181.
7. Piyaphanee W, Krudsood S, Tangpukdee N, et al. Emergence and clearance of gametocytes in uncomplicated Plasmodium falciparum malaria. Am J Trop Med Hyg 2006, 74:432-435.
8. Lawpoolsri S, Klein EY, Singhasivanon P, et al. Optimally timing primaquine treatment to reduce Plasmodium falciparum transmission in low endemicity Thai-Myanmar border populations. Malar J 2009, 8:159.
9. Al-Sweedan SA, Jdaitawi H, Khriesat WM, Khader YY, Al-Rimawi HS Predictors of severe hemolysis in patients with glucose-6-phosphate dehydrogenase deficiency following exposure to oxidant stresses. Hematol Oncol Stem cell Ther 2009, 2:354-357.
10. Rieckmann KH, McNamara JV, Frischer H, Stockert TA, Carson PE, Powell RD Gametocytocidal and sporontocidal effects of primaquine and of sulfadiazine with pyrimethamine in a chloroquine-resistant strain of Plasmodium falciparum. Bull World Health Organ 1968, 38:625-632.